Antibody deficiency after diagnosis can be received intravenous immunoglobulin (IVIG) replacement therapy that is mostly IgG, but it may be enriched with IgM and IgA.

Bone marrow transplantation (BMT) and gene therapy, which remain experimental, can be the solution for those deficiencies caused by genetic abnormalities, for instance, the use of BMT in X-linked agammaglobulinemia.